DOCS / Doximity, Inc. (DOCS) CEO Jeff Tangney on Q4 2022 Results - Earnings Call Transcript

Doximity announced a free new service called DocDefender that can remove a physician's personal phone numbers and addresses from public websites more_horizontal

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Doximity (DOCS). But which of thes more_horizontal

Doximity's valuation and slowing sales growth are turning off many investors. Despite these issues, there is a lot to like about the company, includin more_horizontal

Enphase is the cheapest it has ever been on a free-cash-flow basis. Toro hopes to restart sales growth, armed with a new Lowe's partnership. more_horizontal

Doximity is profitable and boasts high gross and net margins. The company's platform displays the flywheel effect, a powerful moat. more_horizontal

Doximity shares recently fell in response to a revised forward outlook management shared during its fiscal first-quarter earnings report. Over half a more_horizontal

Doximity's revised guidance for the current fiscal year was horrendous. The business is still growing a bit and is highly profitable. more_horizontal

Doximity announced solid fiscal first-quarter 2024 results that exceeded expectations. But the online networking service for medical professionals is more_horizontal